These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11410695)

  • 1. 5-fluorouracil-induced leukoencephalopathy in patients with breast cancer.
    Choi SM; Lee SH; Yang YS; Kim BC; Kim MK; Cho KH
    J Korean Med Sci; 2001 Jun; 16(3):328-34. PubMed ID: 11410695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion-weighted MR imaging of Carmofur-induced leukoencephalopathy.
    Fujikawa A; Tsuchiya K; Katase S; Kurosaki Y; Hachiya J
    Eur Radiol; 2001; 11(12):2602-6. PubMed ID: 11734966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carmofur-induced leukoencephalopathy: MRI.
    Matsumoto S; Nishizawa S; Murakami M; Noma S; Sano A; Kuroda Y
    Neuroradiology; 1995 Nov; 37(8):649-52. PubMed ID: 8748897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil/epirubicin/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients.
    Kluger N; Jacot W; Frouin E; Rigau V; Poujol S; Dereure O; Guillot B; Romieu G; Bessis D
    Ann Oncol; 2012 Nov; 23(11):2879-2884. PubMed ID: 22571858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of manic episode during treatment with 5-fluorouracil, epirubicin and cyclophosphamide for breast cancer.
    Pacchiarotti I; Mazzarini L; Pellegrini P; Venturelli V; Sani G; Sánchez-Moreno J; Mancinelli I; Tatarelli R; Kotzalidis GD; Girardi P
    Gen Hosp Psychiatry; 2007; 29(5):461-3. PubMed ID: 17888816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Late-onset leukoencephalopathy induced by long-term chemotherapy with capecitabine and cyclophosphamide for liver metastasis from breast cancer].
    Yasaki S; Tukamoto Y; Yuasa N; Ishikawa T; Yoshii F
    Rinsho Shinkeigaku; 2012; 52(4):251-6. PubMed ID: 22531658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of two different regimens as neoadjuvant chemotherapy for breast cancer].
    Yang D; Tong F; Cao Y; Liu P; Zhou B; Liu H; Qiao X; Zhang J
    Zhonghua Zhong Liu Za Zhi; 2002 May; 24(3):303-5. PubMed ID: 12515634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Breast carcinoma and bone chondrosarcoma: a new syndrome?].
    Guedin P; Chasle J; Blanc-Fournier C; Lacroix J
    J Radiol; 2006 Nov; 87(11 Pt 1):1700-4. PubMed ID: 17095966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-rounding of adjuvant chemotherapy for breast cancer: an audit of toxicity.
    Jenkins P; Wallis R
    J Oncol Pharm Pract; 2010 Dec; 16(4):251-5. PubMed ID: 19965948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in brain white matter integrity after systemic treatment for breast cancer: a prospective longitudinal study.
    Menning S; de Ruiter MB; Veltman DJ; Boogerd W; Oldenburg HSA; Reneman L; Schagen SB
    Brain Imaging Behav; 2018 Apr; 12(2):324-334. PubMed ID: 28290072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter study of primary systemic therapy with docetaxel, cyclophosphamide and trastuzumab for HER2-positive operable breast cancer: the JBCRG-10 study.
    Ueno T; Masuda N; Sato N; Ohtani S; Yamamura J; Matsunami N; Kashiwaba M; Takano T; Takahashi M; Kaneko K; Ohno S; Morita S; Toi M
    Jpn J Clin Oncol; 2020 Jan; 50(1):3-11. PubMed ID: 31821506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Side effects of FEC100].
    Endo A; Watanabe T; Kodama H; Shiga C; Kikuchi S; Yokota T
    Gan To Kagaku Ryoho; 2008 Mar; 35(3):467-70. PubMed ID: 18347396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut peptide profile and chemotherapy-associated dyspepsia syndrome in patients with breast cancer undergoing FEC60 chemotherapy.
    Riezzo G; Clemente C; Linsalata M; D'Attoma B; Orlando A; Campanella G; Giotta F; Russo F
    Anticancer Res; 2013 Nov; 33(11):4951-7. PubMed ID: 24222135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible leukoencephalopathy caused by 5-fluorouracil derivatives, presenting as akinetic mutism.
    Aoki N
    Surg Neurol; 1986 Mar; 25(3):279-82. PubMed ID: 3080815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical comparison on the safety and efficacy of fluorouracil/pirarubicin/cyclophosphamide (FPC) with fluorouracil/ epirubicin/cyclophosphamide (FEC) as postoperative adjuvant chemotherapy in breast cancer.
    Li Y; Tang JH; Huang XE; Li CG
    Asian Pac J Cancer Prev; 2011; 12(7):1795-8. PubMed ID: 22126567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weekly taxane-anthracycline combination regimen versus tri-weekly anthracycline-based regimen for the treatment of locally advanced breast cancer: a randomized controlled trial.
    Tan QW; Luo T; Zheng H; Tian TL; He P; Chen J; Zeng HL; Lv Q
    Chin J Cancer; 2017 Mar; 36(1):27. PubMed ID: 28270181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute hematologic feasibility of G-CSF supported dose-escalated FEC therapy as adjuvant treatment after breast cancer surgery.
    Ottosson S; Magnusson K; Hultborn R
    Anticancer Res; 1999; 19(5C):4429-34. PubMed ID: 10650787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased prevalence of vitamin D insufficiency in patients with breast cancer after neoadjuvant chemotherapy.
    Jacot W; Pouderoux S; Thezenas S; Chapelle A; Bleuse JP; Romieu G; Lamy PJ
    Breast Cancer Res Treat; 2012 Jul; 134(2):709-17. PubMed ID: 22562178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of acute leukemia following epirubicin-based adjuvant chemotherapy: a report from the National Cancer Institute of Canada Clinical Trials Group.
    Crump M; Tu D; Shepherd L; Levine M; Bramwell V; Pritchard K
    J Clin Oncol; 2003 Aug; 21(16):3066-71. PubMed ID: 12915595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of tolerance and toxicity of CEF-100 regimen versus CEF-60 regimen as adjuvant therapy for breast cancer].
    Hui R; Zhang M; Hao XM; Zhang J
    Zhonghua Zhong Liu Za Zhi; 2007 Nov; 29(11):871-4. PubMed ID: 18396651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.